Outline of designs for experimental vaccines and therapeutics - 20 January 2020

Overview

Agenda items

  1. Overview of emerging data on disease epidemiology
  2. Identification of research priorities and a collaborative process to offer support -if requested- to the national authorities in China and elsewhere.
  3. What is known and what the potential research priorities should be regarding:
    • Diagnostics – individual, population sero-surveys and sequence
    • Therapeutic candidates o Vaccine candidates
    • Data, Sharing, Information Flow
  4. Next steps including considerations of potential spread scenarios vis a vis research priorities
Number of pages
5
Reference numbers
WHO Reference Number: WHO/HEO/R&D Blueprint (‎‎‎‎nCoV)‎‎‎‎/2020.2